Frederick F. Krass

Array ( [id] => 7636392 [patent_doc_number] => 06380267 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Composition and method for decreasing neurologic symptomatology' [patent_app_type] => B1 [patent_app_number] => 09/731362 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3153 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380267.pdf [firstpage_image] =>[orig_patent_app_number] => 09731362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543061 [patent_doc_number] => 06372732 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Use of delta5-androstene-3beta-ol-7, 17-dione in the treatment of lupus erythematosus' [patent_app_type] => B1 [patent_app_number] => 09/554952 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3401 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372732.pdf [firstpage_image] =>[orig_patent_app_number] => 09554952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612705 [patent_doc_number] => 06903130 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders' [patent_app_type] => utility [patent_app_number] => 10/148347 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14314 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903130.pdf [firstpage_image] =>[orig_patent_app_number] => 10148347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982389 [patent_doc_number] => 06927233 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-09 [patent_title] => '5ht2 agonists for controlling IOP and treating glaucoma' [patent_app_type] => utility [patent_app_number] => 10/221458 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1364 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927233.pdf [firstpage_image] =>[orig_patent_app_number] => 10221458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404388 [patent_doc_number] => 06534507 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Methods for treating psychological disorders using bioactive metabolites of gepirone' [patent_app_type] => B1 [patent_app_number] => 09/709741 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4836 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534507.pdf [firstpage_image] =>[orig_patent_app_number] => 09709741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494688 [patent_doc_number] => 06342520 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Locally injectable chemotherapeutics' [patent_app_type] => B1 [patent_app_number] => 09/699913 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8467 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342520.pdf [firstpage_image] =>[orig_patent_app_number] => 09699913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380901 [patent_doc_number] => RE038009 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Zeaxanthin formulations for human ingestion' [patent_app_type] => E1 [patent_app_number] => 09/699985 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12268 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038009.pdf [firstpage_image] =>[orig_patent_app_number] => 09699985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269789 [patent_doc_number] => 06306900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Enteric coated pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 9/694209 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3319 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306900.pdf [firstpage_image] =>[orig_patent_app_number] => 694209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416541 [patent_doc_number] => 06511968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions' [patent_app_type] => B1 [patent_app_number] => 09/694212 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10621 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511968.pdf [firstpage_image] =>[orig_patent_app_number] => 09694212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535151 [patent_doc_number] => 06489357 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Tobacco cembranoids block the expression of the behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptors' [patent_app_type] => B1 [patent_app_number] => 09/693431 [patent_app_country] => US [patent_app_date] => 2000-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 1892 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489357.pdf [firstpage_image] =>[orig_patent_app_number] => 09693431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1515052 [patent_doc_number] => 06420435 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Method for treating gastrointestinal disorders' [patent_app_type] => B1 [patent_app_number] => 09/689151 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1795 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420435.pdf [firstpage_image] =>[orig_patent_app_number] => 09689151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189183 [patent_doc_number] => 06734204 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Serotonin potentiation by oleamide analogs' [patent_app_type] => B1 [patent_app_number] => 09/647447 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 23060 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734204.pdf [firstpage_image] =>[orig_patent_app_number] => 09647447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352505 [patent_doc_number] => 06291441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Method of treating inflammatory bowel disorders' [patent_app_type] => 1 [patent_app_number] => 9/671791 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1966 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291441.pdf [firstpage_image] =>[orig_patent_app_number] => 671791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561463 [patent_doc_number] => 06362167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions' [patent_app_type] => B1 [patent_app_number] => 09/667043 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362167.pdf [firstpage_image] =>[orig_patent_app_number] => 09667043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345756 [patent_doc_number] => 06290996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Method of inhibiting blood platelet aggregation' [patent_app_type] => 1 [patent_app_number] => 9/667042 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1721 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/290/06290996.pdf [firstpage_image] =>[orig_patent_app_number] => 667042 [rel_patent_id] =>[rel_patent_doc_number] =>)